Millennium Pharmacon (Indonesia) Price on November 15, 2023
| SDPC Stock | IDR 154.00 4.00 2.53% |
If you're considering investing in Millennium Stock, it is important to understand the factors that can impact its price. As of today, the current price of Millennium Pharmacon stands at 154.00, as last reported on the 26th of November, with the highest price reaching 160.00 and the lowest price hitting 149.00 during the day. Millennium Pharmacon appears to be very steady, given 3 months investment horizon. Millennium Pharmacon has Sharpe Ratio of 0.0901, which conveys that the firm had a 0.0901% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Millennium Pharmacon, which you can use to evaluate the volatility of the firm. Please exercise Millennium Pharmacon's Mean Deviation of 1.97, risk adjusted performance of 0.0781, and Downside Deviation of 3.4 to check out if our risk estimates are consistent with your expectations.
Millennium Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Millennium |
Sharpe Ratio = 0.0901
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SDPC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.52 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Millennium Pharmacon is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Millennium Pharmacon by adding it to a well-diversified portfolio.
Millennium Pharmacon Valuation on November 15, 2023
It is possible to determine the worth of Millennium Pharmacon on a given historical date. On November 15, 2023 Millennium was worth 161.87 at the beginning of the trading date compared to the closed value of 166.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Millennium Pharmacon stock. Still, in general, we apply an absolute valuation method to find Millennium Pharmacon's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Millennium Pharmacon where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Millennium Pharmacon's related companies.
| Open | High | Low | Close | Volume | |
| 182.48 | 196.21 | 169.72 | 171.69 | 51,375,600 | |
11/15/2023 | 161.87 | 171.69 | 161.87 | 166.78 | 6,253,800 |
| 158.93 | 176.59 | 158.93 | 168.74 | 8,919,300 |
| Backtest Millennium Pharmacon | | | Millennium Pharmacon History | | | Millennium Pharmacon Valuation | Previous | Next |
Millennium Pharmacon Trading Date Momentum on November 15, 2023
| On November 16 2023 Millennium Pharmacon International was traded for 168.74 at the closing time. The highest price during the trading period was 176.59 and the lowest recorded bid was listed for 158.93 . The volume for the day was 8.9 M. This history from November 16, 2023 contributed to the next trading day price upswing. The trading price change to the next closing price was 1.18% . The trading delta at closing time to the current price is 5.88% . |
Millennium Pharmacon Fundamentals Correlations and Trends
By evaluating Millennium Pharmacon's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Millennium Pharmacon's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Millennium financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Millennium Pharmacon Stock history
Millennium Pharmacon investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Millennium is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Millennium Pharmacon will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Millennium Pharmacon stock prices may prove useful in developing a viable investing in Millennium Pharmacon
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
Millennium Pharmacon Stock Technical Analysis
Millennium Pharmacon technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Millennium Pharmacon Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Millennium Pharmacon International cannot be verified against its exchange. Please verify the symbol is currently traded on Jakarta Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Millennium Pharmacon November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Millennium Pharmacon stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Millennium Pharmacon shares will generate the highest return on investment. By undertsting and applying Millennium Pharmacon stock market strength indicators, traders can identify Millennium Pharmacon International entry and exit signals to maximize returns
Millennium Pharmacon Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Millennium Pharmacon's price direction in advance. Along with the technical and fundamental analysis of Millennium Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Millennium to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0781 | |||
| Jensen Alpha | 0.3479 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.056 | |||
| Treynor Ratio | (0.94) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.